ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2015 American Transplant Congress

    Histologic Findings in Pre-transplant AT1Rab + ve Patients Point to an Increase in Sub-Intimal Fibrosis During Acute Rejection and in 12 mo. Protocol Renal Graft Biopsies

    A. González-Almada, J. Arreola-Guerra, E. Cuevas, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Alberu, N. Uribe-Uribe.

    1Transplantation, 1aNephrology-Mineral Metabolism, 1bPathology, Inst Nal de Ciencias Medicas y Nutricion SZ, Mexico City, Distrito Federal, Mexico.

    Previous reports have described an increase in arteritis during acute rejection (AR) in angiotensin II type 1 receptor antibody (AT1Rab) positive (ve+) kidney transplant recipients…
  • 2015 American Transplant Congress

    Preformed Anti-HLA DP Donor Specific Antibodies Are Clinically Significant in Renal Transplantation

    V. Dibbur, M. Willicombe, P. Brookes, R. Sergeant, A. Wardle, D. Taube.

    Renal and Transplant Medicine, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Whilst preformed [PF] anti-HLA A, B, DR and DQ donor specific antibodies [DSAbs] are associated with poorer allograft outcomes secondary to antibody mediated injury,…
  • 2015 American Transplant Congress

    Results of ABO Incompatible Liver Transplantation Using a Simplified Protocol at a Single Institution

    J. Lee,1 J. Lee,1 J. Lee,2 M. Kim,1 M. Ju,1 G. Choi,1 J. Choi,1 S. Kim,1 D. Joo.1

    1Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Department of Surgery, CHA Bundang Medical Center, Bundang, Republic of Korea.

    BackgroundABO incompatible (ABOi) living donor liver transplantation (LDLT) has become a feasible option for patients with end-stage liver disease due to development of various desensitization…
  • 2015 American Transplant Congress

    Everolimus With Low Dose Tacrolimus in Intestinal Transplantation

    T. Beduschi, J. Garcia, J. Lugo-Baruqui, J. Fan, S. Nishida, J. Jebrock, A. Tekin, G. Selvaggi, P. Ruiz, R. Vianna.

    Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL.

    Introduction: Renal dysfunction is a well-known complication after organ transplant given immunosuppression (ISP) with calcineurin inhibitors. This is especially true after intestinal transplant (ITx) given…
  • 2015 American Transplant Congress

    Bortezomib-Based Multi-Modality Protocol for Donor-Specific Antibody Treatment in Lung Transplant Recipients

    M. Vacha, A. Hulbert, J. Byrns, C. Benedetti, A. Finlen Copeland, A. Gray, S. Palmer, L. Snyder.

    Duke University Hospital, Durham, NC.

    Background Donor specific antibodies (DSAs) after lung transplant have been implicated in the development of chronic lung allograft dysfunction and mortality. The ideal treatment strategy…
  • 2015 American Transplant Congress

    A Critical Analysis of the Impact of Socioeconomic Status on Racial Disparities in Kidney Transplantation

    D. Taber, M. Gebregziabher, M. Hamedi, T. Srinivas, K. Chavin, P. Baliga, L. Egede.

    Medical University of South Carolina, Charleston, SC.

    Socioeconomic status (SES) is a significant determinant of health outcomes and may be an important component of racial disparities in kidney transplantation (KTX). While the…
  • 2015 American Transplant Congress

    Molecular and Functional Immune Assays as Non-Invasive Diagnostic Tools to Assess the Risk of Acute Subclinical Rejection After Kidney Transplantation

    O. Bestard,1,2 E. Crespo,1 T. Sigdel,2 S. Roedder,2 Y. Ng,2 J. Cruzado,1 M. Lúcia,1 S.-C. Hsieh,1 T. Tran,1 J. Grinyó,1 M. Sarwal.1

    1Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, CAT, Spain; 2Department of Transplant Surgery, UCSF, San Francisco, CA.

    Subclinical allograft rejection (sc-AR) is still a main cause of allograft loss that can only be assessed through invasive surveillance biopsies. We sought to investigate…
  • 2015 American Transplant Congress

    Once Daily Dosing Is as Effective as Twice Daily Dosing of Immediate Release Tacrolimus

    L. Bowman,1 T. Horwedel,1 J. Hagopian,1 B. Bone,2 H. Wijeweera,2 D. Brennan.2

    1Barnes-Jewish Hospital, St. Louis; 2Washington University School of Medicine, St. Louis.

    Purpose: Extended release (ER) tacrolimus (tac) has been available as Advagraf® for many years and as Astagraf XL® in the US since 2013. Immediate release…
  • 2015 American Transplant Congress

    Alemtuzumab Induction Is Protective Against Acute Rejection in Kidney Recipients With Subtherapeutic Tacrolimus Concentrations

    K. Szempruch, R.-A. Lee, R. Dupuis, J. Deyo, T. Kozlowski.

    Transplant Surgery, University of North Carolina Hospitals, Chapel Hill, NC.

    Purpose: To determine the effect of attaining early therapeutic tacrolimus (TAC) trough concentrations on biopsy-proven acute rejection (BPAR) within 12 months post-transplantation in adult kidney…
  • 2015 American Transplant Congress

    Toll-Like Receptor 4-Signaling Abrogates Inhibitory Effect of Calcineurin Inhibitor on B-Cells Responding to Blood Group A-Antigens

    H. Sakai, Y. Tanaka, H. Ohdan.

    Transplant Unit, Hiroshima University, Hiroshima, Japan.

    Aim: Bacterial infection following ABO-incompatible organ-transplantation is associated with refractory Ab-mediated rejection. Here, we investigated the influence of toll-like receptor (TLR)-signaling, via the binding of…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences